Risk of lung cancer and physical activity by smoking status and body mass index, the Norwegian Women and Cancer Study.
Kristin Benjaminsen BorchElisabete WeiderpassTonje BraatenMerethe Selnes HansenIdlir LicajPublished in: European journal of epidemiology (2018)
We aimed to investigate physical activity (PA) and risk of different histological subtypes of lung cancer according to smoking status and body mass index using repeated measurements in a large cohort of women in Norway. The study sample for the multiple imputation analyses consisted of 86,499 and for the complete-case analysis 80,802 women. Repeated measurements of PA level, smoking habits, weight, and height were available for 54,691 women (63.2%), who were included in repeated measurement analyses combined with multiple imputation to address attrition. Cox proportional hazards regression models were used to calculate hazard ratios with 95% confidence intervals. During a median follow-up of 12.9 years, 866 cases of primary lung cancer were identified. We found an inverse association between PA and lung cancer overall. The results were consistent from multiple imputed data analysis to complete-case analysis of PA and possible confounders. We observed a similar trend for adenocarcinoma, but not for squamous cell or small cell carcinomas. Our findings suggest a more pronounced association between lung cancer overall and PA levels in current and former smokers, and in normal-weight and overweight participants with increasing PA levels. The potential of a modifiable lifestyle factor as PA to reduce the risk of lung cancer independently of smoking status is important in public health.
Keyphrases
- body mass index
- physical activity
- polycystic ovary syndrome
- smoking cessation
- weight gain
- public health
- squamous cell
- data analysis
- pregnancy outcomes
- weight loss
- cardiovascular disease
- type diabetes
- cervical cancer screening
- metabolic syndrome
- pregnant women
- lymph node metastasis
- insulin resistance
- young adults
- bone marrow
- depressive symptoms
- single cell
- mesenchymal stem cells
- rectal cancer
- cell therapy